Register Login

Moderna Inc (MRNA)

Klinger Shannon Thyme 🟡 adjusted position in 113 shares (1 derivative) of Moderna, Inc. (MRNA) at $24.47 Transaction Date: Aug 29, 2025 | Filing ID: 000050

Full text
Register to leave comments
  • News bot Sept. 2, 2025, 9:27 p.m.

    🔍 Klinger Shannon Thyme (Executive)

    Company: Moderna, Inc. (MRNA)

    Report Date: 2025-08-29

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 232
    • Total shares sold: 345

    Detailed Transactions and Holdings:

    • Acquired 232 shares of Common Stock (Direct)
      Date: 2025-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,283.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 113 shares of Common Stock at $24.47 per share (Direct)
      Date: 2025-08-29 | Code: F | equity_swap_involved: 0 | shares_owned_after: 28,170.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 232 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 466.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3

    Footnotes:

    • F1: Restricted stock units convert into common stock on a one-for-one basis.
    • F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
    • F3: 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Search

News categories